Tony Barnett

Publications

  1. 2019
  2. Published

    IDegLira: combining efficacy, durability, and convenience?

    Abd Tahrani & Tony Barnett, Aug 2019, In: The Lancet Diabetes and Endocrinology. 7, 8, p. 584-585 2 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2018
  4. Published

    Once-weekly GLP-1R agonists: Moving the goal posts

    Abd Tahrani & Tony Barnett, 31 Jan 2018, In: The Lancet Diabetes and Endocrinology. 6, 4, p. 260-261

    Research output: Contribution to journalArticlepeer-review

  5. 2017
  6. Published
  7. Published
  8. 2016
  9. Published

    Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus

    Abd Tahrani, Tony Barnett, 1 Oct 2016, In: Nature Reviews Endocrinology. 12, 10, p. 566-592 27 p.

    Research output: Contribution to journalReview articlepeer-review

  10. Published

    Future glucose-lowering drugs for type 2 diabetes

    Tony Barnett, 1 Apr 2016, In: The Lancet Diabetes and Endocrinology. 4, 4, p. 350-359 10 p.

    Research output: Contribution to journalReview articlepeer-review

  11. 2013
  12. Published

    SGLT inhibitors in management of diabetes

    Abd Tahrani, Tony Barnett, Oct 2013, In: The Lancet Diabetes and Endocrinology. 1, 2, p. 140-151 12 p.

    Research output: Contribution to journalReview articlepeer-review

  13. Published

    Obstructive Sleep Apnea and Diabetic Nephropathy: A cohort Study

    Abd Tahrani, Milan Piya, Tony Barnett & Martin Stevens, 23 Sep 2013, In: Diabetes Care.

    Research output: Contribution to journalArticlepeer-review

  14. Published
  15. 2012
  16. Published
  17. Published
  18. Published
  19. Published

    Insulin degludec: a new ultra-longacting insulin

    Abd Tahrani & Tony Barnett, 1 Apr 2012, In: Lancet. 379, 9825, p. 1465-1467 3 p.

    Research output: Contribution to journalEditorial

  20. Published
  21. Published
  22. Published
  23. Published
  24. Published
  25. Published
  26. 2011
  27. Published
  28. Published

    Renal protection with angiotensin receptor blockers: where do we stand?

    Tony Barnett, 1 Sep 2011, In: Journal of nephrology. 24, 5, p. 569-580 12 p.

    Research output: Contribution to journalReview article

  29. Published
  30. Published
  31. Published
  32. Published

    Management of type 2 diabetes: new and future developments in treatment

    Abd Tahrani & Tony Barnett, 1 Jul 2011, In: Lancet. 378, 9786, p. 182-197 16 p.

    Research output: Contribution to journalArticle

  33. Published
  34. Published

    New treatments for type 2 diabetes in the UK - An evolving landscape.

    Tony Barnett, 1 Apr 2011, In: Primary Care Diabetes. 5, 1, p. 1-7 7 p.

    Research output: Contribution to journalArticle

  35. Published
  36. Published
  37. Published
  38. Published
  39. Published

    Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes.

    Tony Barnett, 1 Jan 2011, In: Core evidence. 6, p. 67-79 13 p.

    Research output: Contribution to journalArticle

  40. Published

    SGLT-2 Inhibitors in Development for Type 2 Diabetes Treatment.

    Abd Tahrani & Tony Barnett, 1 Jan 2011, In: The review of diabetic studies : RDS. 8, 3, p. 348-54 7 p.

    Research output: Contribution to journalArticle

  41. 2010
  42. Published

    Bromocriptine: old drug, new formulation and new indication

    Tony Barnett, 1 Dec 2010, In: Diabetes, Obesity and Metabolism. 12, 12, p. 1048-1057 10 p.

    Research output: Contribution to journalArticle

  43. Published
  44. Published

    Emerging treatment options for type 2 diabetes

    Milan Piya, Abd Tahrani & Tony Barnett, 1 Nov 2010, In: British Journal of Clinical Pharmacology. 70, 5, p. 631-644 14 p.

    Research output: Contribution to journalArticle

  45. Published

    Liraglutide, a new diabetes treatment approved by NICE

    Abd Tahrani & Tony Barnett, Nov 2010, In: Practical Diabetes International. 27, 9, p. 377-378 2 p.

    Research output: Contribution to journalArticlepeer-review

  46. Published
  47. Published

    The International Study of Insulin and Cancer

    Tony Barnett, 1 Sep 2010, In: Lancet. 376, 9743, p. 769-770 2 p.

    Research output: Contribution to journalArticle

  48. Published
  49. Published
  50. Published
  51. Published
  52. Published
  53. Published
  54. Published

    Inhaled insulin: new formulation, new trial

    Tony Barnett, 1 Jun 2010, In: Lancet. 375, 9733, p. 2199-2201 3 p.

    Research output: Contribution to journalEditorial

  55. Published

    Glycaemic control in type 2 diabetes: Targets and new therapies

    Abd Tahrani, Milan Piya & Tony Barnett, 1 Feb 2010, In: Pharmacology & Therapeutics. 125, 2, p. 328-361 34 p.

    Research output: Contribution to journalReview article

  56. Published

    Exenatide once weekly: clinical outcomes and patient satisfaction.

    Abd Tahrani, Milan Piya & Tony Barnett, 1 Jan 2010, In: Patient preference and adherence. 4, p. 313-24 12 p.

    Research output: Contribution to journalArticle

  57. 2009
  58. Published

    SMBG: not an area for cost saving

    Tony Barnett, 5 Nov 2009, In: Prescriber. 20, 21, p. 10-12 3 p.

    Research output: Contribution to journalArticle

  59. Published

    Bariatric surgery: A cure for diabetes?

    Shahrad Taheri, Abd Tahrani & Tony Barnett, Nov 2009, In: Practical Diabetes International. 26, 9, p. 356-358 3 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 6 7 Next